TheEdgeResearch
Home / Stocks / ENTA

Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ Healthcare Biotechnology
$7.62 ▼ -4.51%
Market Cap
$222.2M
Sector
Healthcare
Industry
Biotechnology
Beta
0.96
52-Wk Range
7.56-17.15
CEO
Jay R. Luly
Country
US
Currency
USD

Enanta Pharmaceuticals, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Watertown, MA, US. The stock last traded at $7.62, down 4.51% on the session, giving a market capitalisation of $222.2M. On trailing twelve-month figures it carries a trailing P/E of -3.24, a net margin of -108.3%. Its beta of 0.96 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-3.24
Price / Sales
3.53
Price / Book
2.77
EV / EBITDA
-5.08
Gross margin
98.1%
Operating margin
-99.0%
Net margin
-108.3%
Return on equity
—
Debt / equity
0.68
Current ratio
3.78
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
74
IPO date
2013-03-21
Headquarters
Watertown, MA, US
About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV). The company also holds a strategic partnership and licensing agreement with Abbott Laboratories. This collaboration involves the joint identification, development, and market introduction of specific HCV NS3 and NS3/4A protease inhibitor compounds, including known agents like paritaprevir and glecaprevir, which are utilized in the management of chronic hepatitis C virus. Founded in 1995, Enanta Pharmaceuticals, Inc. operates from its principal office located in Watertown, Massachusetts.

Comparable companies

Enanta Pharmaceuticals, Inc. is most often compared with the following Healthcare names:

ASMBAVIRCRBUFHTXIMRXNAUTPRLDPYXSTNYAVYGR
More research on ENTA
ENTA technical analysis ENTA TheEdge Score Compare against peers
Open full interactive analysis & DCF →